Erik Greb joined the staff of Neurology Reviews in January 2012. Since then, he has attended scientific conferences, conducted video interviews, and written about clinical research in multiple sclerosis, epilepsy, Parkinson's disease, Alzheimer's disease, stroke, and other neurologic disorders. In addition to news articles, Erik has written investigative stories about multiple sclerosis, headache, and epilepsy. He previously wrote about pharmaceutical manufacturing, drug formulation and delivery, quality assurance, and regulation for Pharmaceutical Technology.
News
Long-term benefit for DBS in treating Parkinson’s disease motor symptoms
“Both STN and GPi DBS maintained motor benefit out to 10 years, with improvements seen in tremor and rigidity, greater than bradykinesia.”
News
Intranasal third-generation CGRP effective for acute migraine
Among patients taking zavegepant, more than 20% achieved pain freedom and 40% were relieved of their most bothersome symptom.
News
Radially adjustable ‘Tigertriever’ safe, effective in stroke
The novel device may increase the options for endovascular therapy.
News
Neurologic drug prices jump 50% in five years
Most of the increased cost was due to rising costs for neuroimmunology drugs, mainly for those used to treat multiple sclerosis (MS).
News
EEG data may help aid diagnosis, treatment of focal epilepsy
“A patient with epilepsy may have a unique combination of seizure rhythms that can inform the days and timing of his or her highest seizure risk...
News
Prostate drugs tied to lower risk for Parkinson’s disease
If confirmed by additional trials, glycolysis-enhancing drugs could be a new option to slow progression of Parkinson’s disease,
News
Researchers examine factors associated with opioid use among migraineurs
Despite ample evidence of opioids’ harmful effects when administered for migraine, about one-third of migraineurs report taking them.
News
Blood biomarker may predict Alzheimer’s disease progression
P-tau181 and NfL in blood have individual and complementary potential roles in the diagnosis and the monitoring of neurodegenerative disease.
News
High blood pressure at any age speeds cognitive decline
Prehypertension was also linked to accelerated cognitive decline.
News
Blood pressure treatment reduces bleeding in ICH
The management of blood pressure in ICH is complex. Timing, type of drug, and type of patient must be considered.
News
Concussion linked to risk for dementia, Parkinson’s disease, and ADHD
A history of multiple concussions strengthened the association between concussion and subsequent mood and anxiety disorder, dementia, and...
News
Late-onset epilepsy tied to a threefold increased dementia risk
The findings support a bidirectional relationship between dementia and epilepsy.
News
Gene-replacement therapy shows promise in X-linked myotubular myopathy
An investigational gene therapy decreases ventilator dependence and may improve motor development in children with a rare, life-threatening...
News
Ataluren delays disease milestones in patients with nonsense mutation DMD
Patients who received ataluren in addition to standard of care were 2.2 years older when they lost ambulation, compared with patients receiving...